TheraRadar
← Back
Data updated: Mar 29, 2026

ONESOURCE SPECIALTY

Infectious DiseaseImmunologyGastroenterology
Generics

ONESOURCE SPECIALTY is a generic drug manufacturer focused on Infectious Disease, Immunology, Gastroenterology.

1986
Since
40
Drugs
-
Trials
373
Approved (2yr)

Key Drugs

MIDOZALAM HYDROCHLORIDE
midazolam hydrochloride
CNS
2 indications · 2011

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
CETIRIZINE HYDROCHLORIDE ALLERGY 2026-01-30
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 27%
3 drugs
Immunology 27%
3 drugs
Gastroenterology 18%
2 drugs
Metabolic 18%
2 drugs
Dermatology 9%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Infectious Disease, Dermatology, Immunology, Gastroenterology
Merck big-pharma
Infectious Disease, Immunology, Metabolic
PHARMACIA AND UPJOHN big-pharma
Dermatology, Infectious Disease, Immunology, Metabolic
Johnson & Johnson big-pharma
Immunology, Infectious Disease, Metabolic
MALLINCKRODT specialty
Gastroenterology, Dermatology, Metabolic, Immunology